Nipro newsletter April 2026
tjoapck banner – feb 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Merxin March 2026
Chemspec Feb 2026
the bridge – website ad 28/01/2026
Terumo 05/01
SAE Media – pre-filled syringes – East Coast 19/11/25
SAE Media – Pre-filled syringes West Coast 19/11/25
Nipro April 2026

Regenerative Drugbased Cardiac Therapies

Myocardial infarction results from the interruption of blood supply to a part of the heart, causing heart cells to die. This is most due to coronary artery occlusion following the rupture of a vulnerable atherosclerotic plaque. The resulting ischemia and ensuing oxygen shortage, if left untreated for a sufficient period of time, can cause infarction of heart muscle tissue. Dr. Roman Schenk Recardio why regenerative medicine holds the promise of functional restoration by replenishing cardiomyocytes and blood vessels, and therefore also has the potential for complete tissue repair.
https://international-pharma.com/wp-content/uploads/2014/02/Regenerative.pdf

SMI London
Biopharma group march 2026
Interpack Staubli March 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025